Capreomycin: Difference between revisions
m Protected "Capreomycin": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)) |
m Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +) |
||
| Line 20: | Line 20: | ||
}} | }} | ||
{{SI}} | {{SI}} | ||
'''Capreomycin''' is a [[peptide]] [[antibiotic]], commonly grouped with the [[aminoglycoside]]s, which is given in combination with other [[antibiotics]] for [[tuberculosis]]. Adverse effects include [[nephrotoxicity]] and 8th cranial [[neurotoxicity|nerve toxicity]]. | '''Capreomycin''' is a [[peptide]] [[antibiotic]], commonly grouped with the [[aminoglycoside]]s, which is given in combination with other [[antibiotics]] for [[tuberculosis]]. Adverse effects include [[nephrotoxicity]] and 8th cranial [[neurotoxicity|nerve toxicity]]. | ||
| Line 27: | Line 27: | ||
{{Antimycobacterials}} | {{Antimycobacterials}} | ||
[[Category:Tuberculosis]] | [[Category:Tuberculosis]] | ||
[[Category:Aminoglycoside antibiotics]] | [[Category:Aminoglycoside antibiotics]] | ||
Revision as of 23:26, 8 August 2012
| File:Capreomycin IA.svg | |
| File:Capreomycin IB.svg | |
| Clinical data | |
|---|---|
| ATC code | |
| Identifiers | |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C25H44N14O8 |
| Molar mass | 668.706 g/mol |
|
WikiDoc Resources for Capreomycin |
|
Articles |
|---|
|
Most recent articles on Capreomycin Most cited articles on Capreomycin |
|
Media |
|
Powerpoint slides on Capreomycin |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Capreomycin at Clinical Trials.gov Clinical Trials on Capreomycin at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Capreomycin
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Capreomycin Discussion groups on Capreomycin Patient Handouts on Capreomycin Directions to Hospitals Treating Capreomycin Risk calculators and risk factors for Capreomycin
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Capreomycin |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Capreomycin is a peptide antibiotic, commonly grouped with the aminoglycosides, which is given in combination with other antibiotics for tuberculosis. Adverse effects include nephrotoxicity and 8th cranial nerve toxicity.
The drug should not be given with streptomycin or other drugs that may damage the 8th nerve.
- Pages with script errors
- Pages with broken file links
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Tuberculosis
- Aminoglycoside antibiotics